Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methods of gene delivery

N A Wivel1, J M Wilson

  • 1Department of Molecular and Cellular Engineering, University of Pennsylvania School of Medicine, Philadelphia, USA.

Hematology/Oncology Clinics of North America
|July 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fission yeast myosin-II isoforms assemble into contractile rings at distinct times during mitosis.

Current biology : CB·2001
Same author

Anteroapical stunning and left ventricular outflow tract obstruction.

Mayo Clinic proceedings·2001
Same author

Congenital diaphragmatic hernia: where are we and where do we go from here?

Seminars in perinatology·2001
Same author

Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic.

Journal of pediatric surgery·2001
Same author

A quantitative nonimmunogenic transgene product for evaluating vectors in nonhuman primates.

Molecular therapy : the journal of the American Society of Gene Therapy·2000
Same author

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

Journal of virology·2000
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Human gene therapy shows promise, with early studies demonstrating physiologic changes. Future advancements require improved gene delivery vectors, likely synthetic, tailored for specific diseases and organs.

Area of Science:

  • Biomedical research
  • Molecular biology
  • Translational medicine

Background:

  • Human gene therapy is a developing field with potential for disease treatment.
  • Current research provides proof-of-principle but lacks definitive efficacy evidence.
  • Physiologic changes relevant to disease processes have been observed.

Purpose of the Study:

  • To highlight the current state and future challenges in human gene therapy.
  • To emphasize the critical need for enhanced vector design in gene delivery.
  • To project future directions in vector development for targeted therapies.

Main Methods:

  • Review of existing gene therapy studies and their outcomes.
  • Analysis of current limitations in gene delivery systems.

Related Experiment Videos

  • Discussion of fundamental research areas required for vector improvement.

    • Main Results:

    • Gene therapy has shown preliminary success in demonstrating relevant physiologic changes.
    • Current gene delivery vectors are considered rudimentary compared to future potential.
    • No universal vector is anticipated; specialized vectors for specific applications are more likely.

    Conclusions:

    • Significant advancements in human gene therapy are contingent upon the development of more efficient vectors.
    • Future vectors may be synthetic, combining properties of cellular and viral systems.
    • Continued fundamental research in cell biology, virology, immunology, and pathophysiology is essential for progress.